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Human rickettsial diseases comprise a variety of clinical entities caused by microorganisms belonging to the genera Rickettsia,
Orientia, Ehrlichia, and Anaplasma. These microorganisms are characterized by a strictly intracellular location which has, for long,
impaired their detailed study. In this paper, the critical steps taken by these microorganisms to play their pathogenic roles are
discussed in detail on the basis of recent advances in our understanding of molecular Rickettsia-host interactions, preferential
target cells, virulence mechanisms, three-dimensional structures of bacteria eﬀector proteins, upstream signalling pathways and
signal transduction systems, andmodulation of gene expression. The roles of innate and adaptive immune responses are discussed,
and potential new targets for therapies to block host-pathogen interactions and pathogen virulence mechanisms are considered.
1. Introduction
The human rickettsial diseases are a variety of clinical entities
caused by α-proteobacteria of the order Rickettsiales belong-
ing to genera Rickettsia and Orientia (family: Rickettsiaceae)
and Ehrlichia and Anaplasma (family: Anaplasmataceae) [1,
2].
Rickettsiae are small, obligately intracellular, gram-
negative bacteria that reside free in the host cell cytoplasm,
and are transmitted to human hosts by arthropod vectors.
A modern classification based on whole-genome analysis,
divides the species of the genus Rickettsia in four groups:
spotted fever group (R. rickettsii, R. conorii, R. parkeri, and
several others), typhus group (R. prowazekii and R. typhi),
ancestral group (R. bellii and R. canadensis, not known to be
pathogenic), and transitional group (R. akari, R. australis,
and R. felis). Further investigation of a variety of hosts
including nonhematophagous insects, amoebae, and leeches
identified many novel Rickettsia clades opening a broader
view of their evolution [3].
Rickettsia prowazekii is the only pathogen among various
rickettsial species with acknowledged capacity to maintain
persistent subclinical infection in convalescent patients,
which can later manifest as recrudescent typhus or Brill-
Zinsser disease.
Orientia tsutsugamushi is the etiologic agent of scrub
typhus, a rickettsiosis that is widespread in Asia, the islands
of the western Pacific and Indian Oceans, and foci in
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northern Australia. The genus Ehrlichia is member of the
family Anaplasmataceae, which also includes the genera
Anaplasma, Wolbachia, and Neorickettsia. It consists of
six formally named members: E. canis, E. chaﬀeensis, E.
ewingii, E. muris, E. Ovis, and E. ruminantium. Human
monocytic ehrlichiosis, caused by E. chaﬀeensis, and human
granulocytic anaplasmosis, caused by Anaplasma phago-
cytophilum, are the most important ehrlichioses and are
considered emerging diseases. Major findings in rickettsioses
and ehrlichioses/anaplasmosis include fever in a patient
with exposure to a potential vector that may be associated
with rash, inoculation eschar, or localized lymphadenopathy.
Laboratory studies commonly reveal neutropenia, thrombo-
cytopenia, and moderate increases in hepatic transaminases.
The severity of rickettsial diseases varies with the causative
agent and the host. Older age, alcoholism, and deficit in
glucose-6-phosphate dehydrogenase have been associated
with more severe disease [1, 2].
For each genus, the main steps taken by the microor-
ganism to play their pathogenic roles will be discussed with
particular emphasis to the roles of innate and adaptive
immune responses.
2. Rickettsia spp
2.1. Endothelial Cell Invasion, Injury, and Activation. Al-
though pathogenic rickettsiae are able to infect and replicate
in vitro in a great number of diﬀerent cell types, during
in vivo infection, both in humans and in established
experimental models of infection, the pathogens invade and
proliferate within vascular endothelial cells (ECs) lining
small and medium-sized blood vessels, the major target
cells of rickettsial infection, together, to a lesser extent,
with perivascular cells, that is, monocytes and macrophages,
and hepatocytes, destroying them, spreading infection to
the endothelia of the vascular tree. The recently emerging
concept of “ECs heterogeneity” considers the significant
morphological and functional diﬀerences between ECs of
small and large vessels and between cells derived from
various microvascular endothelial beds, and the necessity
for a more comprehensive analysis of the biological basis
of rickettsial aﬃnity for vascular ECs (see below). However,
damage to the endothelium, and subsequent endothelial
dysfunction and activation, is followed by acute phase
responses and alteration in coagulation and in the cytokine
network, together with transient immune dysregulation,
characterized by reduction in circulating peripheral CD4+
T lymphocytes and perivascular infiltration by CD4 and
CD8 T lymphocytes, B cells, and macrophages, all features
collectively termed as “rickettsial vasculitis”. Themechanisms
of host defence are not yet completely understood, although
cell-mediated immunity is thought to play a crucial role
[4, 5].
2.1.1. ECs Invasion. Rickettsial entry into human ECs via
induced phagocytosis requires rickettsial viability and eﬀec-
tor function of the host cell cytoskeletal actin, implicating
that adherence of a viable bacterium to the cell surface trig-
gers intracellular uptake by a metabolically active host cell.
Even though some signalling events involved in rickettsial
entry into the ECs have been documented, that is, activation
of phosphoinositide 3-kinase, Cdc42 (a small GTPase),
src-family tyrosine kinases, and tyrosine phosphorylation
of focal adhesion kinase (FAK) and cortactin, all of the
eﬀector host proteinsmediating entry are not fully elucidated
(Figure 1) [6].
Some studies, especially on spotted fever group rick-
ettsiae (R. rickettsii and R. conorii), have reported the
Ku70 subunit of a mainly nuclear DNA-dependent protein
kinase, located in cytoplasm and plasma membrane too,
as a receptor involved in rickettsial internalization. Ku70
is recruited to rickettsial entry sites, and inhibition of
its expression impairs rickettsial internalization. Rickettsial
infection also stimulates the ubiquitination of this kinase.
The ubiquitin ligase c-Cbl is recruited to rickettsial entry foci,
and downregulation of c-Cbl blocks rickettsial invasion and
Ku70 ubiquitination. Experimental approaches identified the
rickettsial outer membrane protein B (OmpB) as a ligand
for Ku70 and that Ku70-OmpB interactions are suﬃcient
to mediate rickettsial invasion of nonphagocytic host cells.
Furthermore spotted fever group rickettsiae use OmpA,
Sca1, and Sca2 as adhesion proteins [7]. Antibodies to
particular epitopes of OmpA and OmpB may protect against
reinfection, but they appear not to play a key role in immu-
nity against primary infection [8]. OmpA, OmpB, Sca1,
and Sca2 belong to a family of outer membrane proteins,
termed autotransporters, found in gram-negative bacteria.
Bioinformatic analysis of sequenced rickettsial genomes has
identified a family of at least 15 genes in addition to ompA
(sca0) and ompB (sca5), termed sca (for surface cell antigens),
whose predicted products resemble autotransporter proteins.
The function of all of these Sca proteins remains unknown.
However, it was hypothesized that they should contribute to
the specific recognition of diﬀerent sets of host receptors. It is
possible that Sca1 and Sca2 may work in concert with other
rickettsial proteins (i.e., OmpB and OmpA) to interact with
target mammalian cells, especially ECs during the infection
process. The interactions of Sca1 and Sca2 with their cognate
receptors may be coordinated with other receptor-ligand
pairs to trigger previously observed downstream signaling
events, that is, phosphoinositide 3-kinase, Cdc42, and src-
family tyrosine kinases that, ultimately, lead to localized actin
recruitment and nucleation required for entry [9–11].
Other possible rickettsial adhesins, encoded by the genes
RC1281 and RC1282 in R. conorii, and, respectively, designed
as Adr1 and Adr2, have been proposed to be also involved in
bacterial adhesion and entry into the host cells [12].
The rickettsiae induce internalization by phagocytosis.
Then, to enter the cytosol of the host cell, where nutrients,
adenosine triphosphate, amino acids, and nucleotides, are
available for growth, and to avoid phagolysosomal fusion and
death, rickettsiae must escape from the phagosome. Rick-
ettsiae secrete phospholipase D and heamolysin C, encoded
by the rickettsial genes pld and thyC which are capable of
disrupting the phagosomal membrane and allowing a rapid
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Figure 1: Rickettsia entry into endothelial cells.
escape. However, knockout of the pld gene alone does not
prevent phagosomal escape [13].
In the cytosol, rickettsiae express a surface protein, Sca2,
which recruits the Arp2/3 complex, activate it inducing
directional host actin polymerization, which, finally, propels
the bacterium through the cytoplasm and across the cell
membrane into the adjacent endothelial cell or extracellular
space. On its own, the Arp2/3 complex has no actin
nucleation activity. It is activated by a class of cellular
proteins called nucleation-promoting factors (NPFs), two
examples of which are members of the Wiskott-Aldrich
syndrome protein (WASP) family and of the cortactin family.
RickA, a mimic of WASP family NPFs, has been proposed
as the mediator of Arp2/3 recruitment and actin nucleation.
However, the evidence for a role for Sca2 including gene
knockouts and complementation is more extensive and
compelling [14].
Then filaments of actin propel Rickettsia to the surface of
the host cell, where host cell membrane is deformed outward
and invaginates into the adjacent cell. Disruption of both
cell membranes enables the Rickettsia to enter the adjoining
cells without being exposed to the extracellular environment.
However, some rickettsiae exit via the luminal surface of
blood vessels into the bloodstream [15, 16].
Typhus group rickettsiae tend to accumulate within the
cytoplasm until cell lysis as R. prowazekii does not stimulate
actin-based mobility and R. typhi exhibits only erratic
mobility. Spotted fever group organisms spread rapidly
from cell to cell and usually accumulate intracellularly in
significantly lower numbers than typhus group rickettsiae.
It would be reasonable to hypothesize that the host cell is
able to sustain growth, multiplication, and accumulation
of progeny rickettsiae during infection with typhus group
organisms, owing to significant diﬀerences in pathogenic
mechanisms of cell injury in comparison to those triggered
by spotted fever group rickettsiae, that is, diﬀerences in the
intensity and/or kinetics of the nuclear-factor- (NF-) κB
activation pattern in R. Typhi- versus R. conorii-infected host
ECs (see below) or stimulation of oxidative stress [17].
In addition to the above-mentioned rickettsial mecha-
nisms of EC invasion, several studies pointed out the role
of T4SS as an additional virulence factor. T4SSs are complex
multiprotein structures spanning the bacterial envelope and
are composed of up to 12 individual protein components
classified into three groups, each represented in this bacterial
genus. The exact function of these transporters, which are
ancestrally related to bacterial conjugation systems, diverged
during evolution. Since T4SS components are retained in
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rickettsial genomes, many of which lack plasmids; their
primary suspected role is secretion of virulence factors rather
than conjugation. Among rickettsial substrates susceptible
to be exported by such a secretion system are sec7 proteins
(eﬀectors known to contribute to the establishment of
a replicative organelle by inhibiting phagosome-lysosome
fusion, even if these bacteria grow in the cytoplasm of
infected cells), LepA (a protein promoting release of bac-
teria from protozoa by an exocytic pathway, a marker of
probable ancestral location of rickettsiae within ameba), and,
finally, VipD (a protein belonging to the patatin family of
proteins, with phospholipase A2[PLA2] activity that perturbs
membrane traﬃcking and modulates intracellular bacterial
growth) [18].
Factors secreted by the T4SS most likely promote rick-
ettsial survival by triggering synthesis of nutrients from
the host cell or allowing adaptation of rickettsiae to the
intracellular environment [19].
2.1.2. ECs Injury. Themechanisms responsible for cell injury
and vascular denudation by rickettsiae remain poorly under-
stood (Figure 2) [20]. A comprehensive analysis of damage
to the membrane structure and integrity of subcellular
organelles by electron microscopy indicated the possibility
of involvement of reactive oxygen species (ROS) production,
that is, superoxide anion (O2
−), hydrogen peroxide (H2O2),
and hydroxyl radical (OH−), induced by the combina-
tion of tumor-necrosis-factor- (TNF-) α and interferon-
(IFN-) γ, in rickettsial pathogenesis, both as host defense and
infection-induced injury mechanisms. In vitro and in vivo
experiments demonstrated the induction of oxidative stress
mechanisms, as evidenced by accumulation of ROS, altered
levels of antioxidant enzymes, that is, superoxide dismutase,
glutathione peroxidase, glutathione reductase, glucose-6-
phosphate dehydrogenase (G6PD), and catalase, alterations
in mRNA expression of selected antioxidant enzymes, and
depleted levels of intracellular reduced thiols, for exam-
ple, reduced glutathione (γ-glutamylcysteinylglycine). These
studies suggest an important role for oxidant-mediated cell
injury in the pathogenesis of rickettsial infections. In addi-
tion, compared to subjects expressing physiologic levels of
G6PD, the prognosis in G6PD- deficient patients is relatively
poor, due to complications, such as hemolysis (involving
red blood cells which lack the ability to synthesize G6PD
to replace unstable prematurely denatured G6PD) and acute
renal failure (as consequence of hemolysis), and enhanced
severity of disease. These observations confirm the potential
importance of antioxidant defence in the outcome of human
rickettsial infections [21, 22]. In this context, it has also
been demonstrated that rickettsial infection in vitro as well
as in vivo induces the expression of hemeoxygenase-1 (HO-
1), the inducible form of antioxidant and vasoprotective
isozyme 1 of heme oxygenase, a rate-limiting enzyme in
the pathway for heme catabolism, resulting in the release of
ferrous iron and generation of carbon monoxide (CO) and
biliverdin. The latter is subsequently converted to bilirubin.
One of the most critical regulatory functions of HO-1 in the
vasculature is to control the activity of the cyclooxygenase
(COX) system, which is responsible for generation of a
number of vasoactive substances, including prostaglandins
(PGs), prostacyclin, and thromboxanes. Rickettsial infection
of human ECs causes robust induction of COX-2 mRNA
and protein expression but has no apparent eﬀect on the
constitutive COX-1 isoform. Induction of the endothe-
lial COX-2 system and the resultant enhanced release of
vasoactive PGs, especially PGE2 and PGI2, may contribute
to the regulation of inflammatory responses and vascular
permeability changes during rickettsial infection [23, 24].
Cell injury and vascular denudation of the endothelium
may also result from direct damage to host cells. One among
possible mechanisms of direct damage is a rickettsial phos-
pholipase activity, that is, phospholipase D or phospholipase
A2, that may contribute to direct host damage. Spotted
fever group rickettsiae may also damage cells at the time of
exiting, when directional actin polymerization is followed
by membrane rupture. Otherwise, typhus group rickettsiae,
which lack directional actin polymerization (R. typhi poly-
merizes actin, but not directionally), grow inside infected
cells until the cells burst, and, in this context, genes, encoding
proteins with possible membranolytic activities, for example,
pat1 and tlyC, could play a role [25]. Another widely
accepted concept regarding the pathogenesis of EC injury
and rickettsial diseases is increased vascular permeability,
resulting in fluid imbalance and edema of vital organs, as a
major feature of acute inflammation. R. conorii infection of
human ECs induces changes in the localization and staining
patterns of adherens junction proteins, and discontinuous
adherens junctions lead to formation of interendothelial
gaps. Interestingly, proinflammatory cytokines, that is, TNF-
α and IFN-γ, during infection, exacerbate the eﬀects of
rickettsiae on endothelial permeability, further suggesting
that the changes in the barrier properties of vascular
endothelium are likely due to a combinatorial eﬀect of
intracellular rickettsiae and immune responses mediated by
and/or directed against the infected host cell [26].
2.1.3. EC Activation: Intracellular Signaling Mechanisms.
It is widely accepted that interactions between invading
rickettsiae and host ECs constitute one of themost important
aspects underlying the onset and progression of infection,
replication within the intracytoplasmic niche, dissemination
through the host, and the pathogenesis of resultant disease.
In vitro studies suggest that ECs undergo a series of active
cellular responses during infection with rickettsiae, resulting
in significant alterations in the pattern of gene transcription
and characteristic responses, a phenomenon referred to as
“endothelial activation” [20].
Many pathophysiological situations aﬀecting ECs of the
vasculature, for example, rickettsial invasion, lead to the
expression of genes dependent on the NF-κB family of tran-
scription factors. Most of the early-response genes transcrip-
tionally upregulated in response to rickettsial invasion, that
is, IL-8 and Monocyte-Chemoattractant-Protein-(MCP-) 1
(see below), contain NF-κB binding sites in their promoter
regions, indicating that infection-induced alterations in gene
expression may be governed, at least in part, by activation
of NF-κB. Human ECs infected with rickettsiae display
nuclear translocation of NF-κB. This event is a consequence
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Figure 2: Rickettsia injury to endothelial cells.
of the degradation, by proteasomes, of masking regulatory
proteins, termed inhibitors of NF-κB, or IκB, after their
phosphorylationmediated by IκB kinase (IKK) complex, and
the exposure of the nuclear location sequences. However, R.
rickettsii is also capable of directly interacting with NF-κB
in its inactive form in the EC cytoplasm by an unidentified
bacterial protease activity [27, 28]. Several studies have also
suggested a role for protein kinase C (PKC), in the activation
of NF-κB by infectious agents, such as rickettsiae, and other
stimuli [29].
Mitogen-activated protein kinases (MAPKs) also play
a critical role in signal transduction events. Three major
MAPK cascades, namely, extracellular signal-regulated
kinases, c-Jun-N-terminal kinases, and p38 MAPK, have
been identified and characterized, and they can be activated
simultaneously or independently to constitute a central
regulatory mechanism that coordinates signals originating
from a variety of extracellular and intracellular mediators.
Activation of enzymes in the MAPKs module by proinflam-
matory cytokines, reactive oxygen species (ROS), and shear
stress transmits signals down the cascade, resulting in phos-
phorylation of many proteins with substantial regulatory
functions throughout the cell, that is, NF-κB. R. rickettsii
infection selectively induces activation of p38 MAPK in ECs.
Activation of p38 MAPK depends on active cellular invasion
by viable rickettsiae, appears to involve generation of ROS,
and subsequently facilitates host-cell invasion by R. rickettsii
[30].
2.1.4. ECs Production of Cytokines. Human umbilical vein
ECs (HUVECs) infected by R. conorii actively secrete
large amounts of IL-6 and IL-8 via an IL-1α-dependent
pathway (Figure 3). Induced expression of genes encoding
these proinflammatory cytokines occurs through signaling
mechanisms that require activation of p38 MAPK and NF-
κB (see above) [31]. IL-1α, produced by HUVECs, remains
associated with the cells, anchored to the cell surface via fatty
acid acylation or through a lectin-like mechanism, mainly in
a precursor form. Therefore, IL-1α precursor, produced by
HUVECs, can be secreted and immediately bound to type
I IL-1 receptor. Thus, IL-1α can act as an autocrine and
paracrine factor onHUVECs, without being detectable in the
supernatants [32]. Alternatively, IL-1α can be active without
being secreted, fixed on endothelial surface membranes, in a
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cell-cell membrane interaction. IL-1α activates ECs, induces
the production of other cytokines, such as IL-8 and IL-6, and
increases the expression of adhesion molecules on both ECs
and leukocytes [33].
IL-6 and IL-8 might play a role in the development
of vasculitis induced by rickettsial infection. IL-6 may
mediate acute-phase protein production associated with
rickettsial infection. IL-6 might also be involved in the
local diﬀerentiation and proliferation of T lymphocytes,
through its stimulatory eﬀects on IL-2 production and IL-2
receptor (IL-2R) expression on T cells and on B-lymphocytes
stimulation [34]. IL-8 is amember of the chemokine family, a
group of structurally related proteins with proinflammatory
properties [35]. IL-8 is a powerful chemotactic agent for
polymorphonuclear leukocytes, stimulates polymorphonu-
clear leukocyte transendothelial migration, and activates
their functions, but it seems to have no eﬀect on ECs
[36].
2.1.5. EC Production of Cellular Adhesion Molecules and
Chemokines. Rickettsial infection of ECs, through the release
of early-response cytokines (IL-1α and IL-6) and other com-
ponents of the acute phase reaction, enhances the expression
on the surface of ECs and polymorphonuclear leukocytes
of cellular adhesion molecules (CAM), that is, E-selectin,
VCAM-1, and ICAM-1, and it has been demonstrated that
the enhanced rolling and the adherence of mononuclear cells
to infected ECs involves E-selectin-, VCAM-1-, and ICAM-
1-dependent mechanisms (Figure 3) [37]. Selectin molecules
(P, L, and E), interacting with cell surface carbohydrate
counterreceptors (sialyl Lewis X family), mediate rolling of
the leukocytes along the vascular endothelial surface, in such
a way that slows the leukocytes in the circulatory flow [38].
This permits adhesion of leukocytes to endothelial -cell-
expressed adhesion molecules at the site of inflammation
[39].
During the acute phase of boutonneuse fever (BF) (i.e.,
within 2 weeks after the onset of symptoms), soluble forms of
these adhesion molecules (sL-selectin, sE-selectin, s-VCAM-
1, and sICAM-1) are shed into plasma by proteolytic cleav-
age of their membrane-bound counterparts from activated
leukocytes and ECs and/or by diﬀerential splicing of their
mRNA. The shed forms are functionally active and could
be involved in the control of adhesive interactions between
cells. In particular, the increase in their levels might reduce
adhesion of leukocytes and exert anti-inflammatory eﬀects,
reducing local lymphocyte and monocyte infiltration. sL-
selectin and s-VCAM-1 return to the normal range in the
third week, whereas sE-selectin and sICAM-1 persist at
significantly high levels even after the third week of disease.
Since a direct correlation between sL-selectin and fever has
been demonstrated, normalization of serum levels may result
in good prognosis, whereas persistence of high levels of this
CAM has negative prognostic value and could be useful to
monitor disease evolution. The lack of correlation among
these soluble CAMs, serum secretion cytokines (i.e., IL-1α
and IL-6), and the absolute number of leukocytes can partly
be explained by the observation that the eﬀects of these
cytokines on cell surface CAM expression do not parallel
the soluble CAM production, and the absolute number of
leukocytes depends on the variable sources of these soluble
molecules, which, in turn, bind diﬀerent cell types. Diﬀering
from other CAMs, levels of sE-selectin directly correlate with
the number of circulating neutrophils. Therefore, sE-selectin
might be an important factor in reducing the quantity of
local neutrophils [37].
Recently, a greater inflammatory EC response to R.
conorii than that to R. africae was observed. These are,
respectively, the etiologic agents of severe (BF) and mild
(African tick bite fever, ATBF) forms of spotted fever
group rickettsioses, characterized by marked increase in IL-
8, MCP-1, and adhesion molecules in EC, involving Toll-like
receptor 4 (TLR4) activation (see below). Importantly, there
is evidence of a similar pattern in vivo, with increased serum
levels of IL-8, VCAM-1, and E-selectin in patients with BF
as compared with those with ATBF. These findings suggest
a greater R. conorii inflammatory potential in ECs than in
infection with R. africae related to the more severe systemic
inflammation and clinical disease in the former rickettsial
infection [40].
Finally, in experimental models of R. conorii infec-
tion of endothelium, there is prominent expression of
chemokines CCL2, CCL3, CCL4, CCL12, CX3CL1, CXCL1,
CXCL9, CXCL10, and Regulated by Activation, Normal
T-cell Expressed and Secreted (RANTES). In particular,
increased expression of CXCL1 appears to coincide with
infiltration of macrophages into R. conorii-infected tissues,
whereas expression of CXCL9 and CXCL10, known to target
activated T cells through CXCR3, is significantly increased in
mice infected with R. conorii. Rickettsiae-triggered activation
of p38MAPK andNF-κBmay triggermost of these responses
[41].
2.1.6. ECs Intracellular Killing of Rickettsiae. Perivascular
infiltrations of CD4+ and CD8+ T lymphocytes, natural
killer cells, macrophages, marginated elements of blood, and
infected ECs themselves secrete cytokines and chemokines
that activate infected ECs, macrophages, and hepatocytes,
by paracrine and autocrine stimulation, to kill intracellular
rickettsiae [12]. Therefore, the mechanism of killing of
R. conorii within human target cells, mainly endothelium,
and, to a lesser extent, macrophages and hepatocytes, has
not been fully determined. Human cells might be capa-
ble of controlling rickettsial infections intracellularly, the
most relevant location in these infections, by a cytokine-,
chemokine- (i.e., RANTES), and a nitric oxide-dependent
mechanism, and, in particular, by one or a combination
of three diﬀerent possibilities involving, (1) nitric oxide
synthesis, (2) hydrogen peroxide production, (3) tryptophan
degradation [42, 43].
AKN-1 cells (human hepatocytes) stimulated by IFN-
γ, TNF-α, and RANTES killed intracellular rickettsiae by
inducible nitric oxide synthase (iNOS) expression and nitric
oxide-dependent mechanism. HUVEC, when stimulated
with the same concentrations of cytokines and RANTES,
diﬀered in their capacity to kill rickettsiae by a nitric oxide-
dependent mechanism and in quantity of nitric oxide syn-
thesized. Hydrogen-peroxide-dependent intracellular killing
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Figure 3: Cytokine production and induction of cellular adhesion molecules in rickettsial diseases.
of R. conorii was demonstrated in HUVECs, THP-1 cells
(human macrophages), and human peripheral blood mono-
cytes activated by cytokines. Rickettsial killing in a human
macrophage cell line was also mediated by a limitation of
the availability of tryptophan in association with expression
of the tryptophan-degrading enzyme indoleamine 2, 3-
dioxygenase (IDO), resulting in its intracellular depletion
and starvation for the bacteria [44].
2.1.7. Regulation of Programmed EC Death . While apoptosis
of infected cells is an important host defense mechanism
for limiting spreading of infection, viruses and intracellular
bacteria employ a variety of strategies to inhibit the host
cell’s apoptotic machinery to ensure and enhance the survival
of the host, as a cell that dies upon infection is a cell that
does not provide a niche for the intracellular pathogen’s
multiplication. The first evidence supporting this behaviour
was demonstration that the antiapoptotic functions of NF-
κB are essential for survival of ECs during R. rickettsii
infection [45]. Infection of cultured human ECs with R.
rickettsii with simultaneous inhibition of NF-κB induces
activation of apical caspases-8 and -9 and also of executioner
enzyme, caspase-3. The peak activity of caspase-3 coin-
cides with the cleavage of poly-(ADP-ribose)-polymerase,
followed by DNA fragmentation, mitochondrial damage,
and, finally, apoptosis. Thus, activation of NF-κB is required
for the maintenance of mitochondrial integrity of host cells
and protects against infection-induced apoptotic death by
preventing activation of the caspase-8- and -9-mediated
pathways [46]. The B-cell lymphoma-2 (Bcl-2) family of
proteins, which includes both pro- and antiapoptotic factors,
plays a critical role in regulation of apoptotic cell death by
controlling mitochondrial permeability [47]. Determination
of the eﬀects of NF-κB on the inhibition of proteins of the
Bcl-2 family during in vitro EC infection by R. rickettsii
further reveals significant changes in expression of various
pro- and antiapoptotic proteins, the ultimate outcome
of which is an “equilibrium shift” towards inhibition of
apoptosis [48].
2.1.8. Heterogeneity of Macrovascular and Microvascular
ECs Response to Rickettsial Infection. The recently emerging
concept of “EC heterogeneity” dictates that, depending
on their location and physiological functions, vascular
endothelium of diﬀerent organ systems displays signifi-
cant diﬀerences in its biological properties and activation
patterns in response to known stressors. In this contest,
recent studies have provided evidence for relatively similar
levels of infectivity and activation of both NF-κB and p38
MAPK, as common signalingmechanisms, andHO-1mRNA
expression in diﬀerent types of macro- (e.g., pulmonary
artery cells) and microvascular (e.g., human dermal, brain,
and pulmonary endothelium) ECs infected with R. rickettsii.
Although systematic comparative analysis of mechanisms
underlying hosts cell’s transcriptional activation illustrates
activation of NF-κB and p38 MAPK in all microvascular cell
types tested, that is, human dermal, brain, and pulmonary
endothelium, the most striking changes in terms of intensity
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of R. rickettsii-induced responses were observed in dermal
ECs. Correspondingly, infected ECs were also found to
secrete the largest amounts of IL-8 and MCP-1. Interestingly,
refractoriness of brain-derived microvascular endothelium
to secrete chemokines in response to infection was also
revealed despite evidence for the activation of NF-κB and
p38 upstream signalling mechanisms and reduced ability
of microvascular ECs to induce COX-2 expression and,
consequently, secretion of PGE2 in response to R. rickettsii
infection. In contrast, R. rickettsii infection of large vessel
ECs, that is, those isolated from human pulmonary artery,
produces significant amounts of PGE2, which may be
attributable to increased activity of COX-2. Absence of any
change in COX-2 activity during microvascular R. rickettsii
infection suggests that the observed alterations in vascular
permeability of cerebral ECs (i.e., cerebral edema) apparently
involve PG-independent mechanisms [49].
2.2. Platelet and Hemostatic/Fibrinolytic Systems’ Activation.
In the acute phase of BF, by measurements of a major
metabolite of thromboxane (TX) in the urine (11-dehydro-
TXB2), a marker of platelet activation and of plasma pro-
thrombin fragment 1+2, the levels of which reflect activation
of prothrombin to thrombin; the occurrence of TXA2-
dependent platelet activation and thrombin generation has
been demonstrated in vivo. These phenomena could, at
least partly, reflect the clinical manifestations of BF, such as
vasculitis and focal microthrombus formation [50].
In addition, recently, a putative biochemical link has
been demonstrated between endothelial dysfunction and
platelet activation by investigating in vivo the generation
of F2-isoprostanes. This family of bioactive iso-eicosanoids
is produced from arachidonic acid through a process of
nonenzymatic free-radical-catalyzed lipid peroxidation, and
their biological activities may transduce the eﬀect of oxidant
stress into specialized forms of cellular activation [51].
Oxidative stress, induced in ECs by R. conorii, with increased
lipid peroxidation, as shown by increased generation of
F2-isoprostanes, causes endothelial dysfunction, as demon-
strated by enhanced ADMA (asymmetric dimethylarginine)
[52] levels.
ADMA is an endogenous inhibitor of NO synthase, able
to cause reduced NO bioavailability and, thus, endothelial
dysfunction. The close relationship between production of
F2-isoprostanes and ADMA levels seems to confirm the
hypothesis that R. conorii infection, inducing oxidative stress,
could, in turn, provoke endothelial dysfunction [53].
Furthermore, endothelial activation, induced by rick-
ettsial infection, associated with systemic inflammation can
induce platelet activation with consequent CD40L release, as
demonstrated in African tick bite fever, by R. africae, and
in BF [52, 54]. CD40L is a transmembrane glycoprotein,
belonging to the tumor necrosis factor family, originally
identified on CD4+ T cells, but also found in platelets. It
is estimated that >95% of the circulating CD40L is derived
from platelets. Binding of soluble CD40L (sCD40L) to
various vascular cells (e.g., ECs or monocytes) contributes to
the pathogenesis of inflammatory and thrombotic processes,
as a further inflammatory stimulus to endothelial activation.
Thus, once established, enhanced sCD40L shedding from
platelets may sustain a vicious circle, persisting even after
recovery, at a time when clinical manifestations of disease
and the systemic inflammatory reaction apparently had
waned [55, 56].
Rickettsial diseases are generally also associated with
significant changes in the levels of hemostatic/fibrinolytic
proteins, demonstrated by pronounced alterations in plasma
concentrations of coagulation factors, natural anticoagu-
lants, and components of the fibrinolytic system. An eleva-
tion in levels of plasma fibrin(ogen)-degradation products
during R. rickettsii and R. conorii infection of humans indi-
cates activation of the fibrinolytic system, as increased levels
of circulating fibrinogen likely reflects enhanced synthesis
of this acute-phase protein. The presence of circulating
C1-inhibitor-kallikrein complex and lower concentrations
of prekallikrein indicate activation of the kallikrein-kinin
system during spotted fever rickettsioses. Rickettsia-infected
ECs acquire a procoagulant phenotype. Rickettsial infection
induces expression of tissue factor, secretion of plasminogen
activator inhibitor, production of platelet-activating factor,
expression of thrombomodulin, and release of von Wille-
brand factor. However, disseminated intravascular coagula-
tion occurs rarely even in lethal cases and is not a common
feature of rickettsioses [57].
2.3. Acute Phase Response. In BF, invasion and proliferation
of rickettsiae in ECs are the events responsible for destruc-
tion of vessels and for acute-phase response activation.
Some acute-phase responses appear to be involved in the
promotion of inflammatory events (IL-1α, IL-8, IFN-γ,
complement proteins, C-reactive protein (CRP), and fibrino-
gen), while others appear to moderate them (ceruloplasmin
and α1-antitrypsin). After the resolution of infection, all
mediators return to the normal range, acute-phase response
subsides, and the homeostatic balance is restored (Figure 4).
IL-1α is not detectable in the blood of acute BF patients,
probably because stimulation of ECs causes the production
of IL-1α predominantly in a cell-associated form, thus
contributing to the localized procoagulant and inflammatory
responses which occur during rickettsial disease. Unde-
tectable serum levels of IL-8 may be due to its prevalent
presence in endothelial protrusions, either in vesicles (the
Weibel-Palade bodies) or on the plasma membrane, which
could be responsible for neutrophil adhesion. As for IFN-γ,
an increase has been detected in the first week, and it oﬀers
a good explanation of the complement data. In fact, IFN-γ
is the main inducer of C4 gene expression, acting, at least
partly, on control of its transcription. Concerning factor B, its
rate of gene transcription is increased by IFN-γ, whereas IL-1
and IL-6 act synergistically at the pretranslational level. Since
in BF IL-1 is not increased and IL-6 is very high during the
first two weeks of infection, IL-6 could play a role with IFN-
γ in active synthesis of factor B in the liver. The high levels
of CRP detected in the acute phase of BF could by binding
cells further induce activation of the classical complement
pathway. This, by generating C5a, in turn, triggers the influx
of neutrophils and enhances the phagocytosis of the cells
that have bound CRP and complement, thereby enhancing
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inflammation and tissue damage. On the other hand, CRP
and complement could prove useful for elimination of
infected, damaged or compromised cells, exerting anti-
inflammatory activities. The increase in fibrinogen levels, in
the first week of BF infection, constitutes the primary event
inducing the local activation of haemostasis, through platelet
activation, and it is a cursory indicator of inflammation in
most human infections. The strong release of ceruloplasmin
could minimize the inflammatory response, acting as a
scavenger of oxygen free radicals produced by macrophages,
neutrophils, and ECs. In fact, ceruloplasmin, in BF patients,
returns to a baseline level nearly contemporaneously with the
normalization of the white blood cell counts. α1-antitrypsin
persists at high levels, in BF patients, until the third week,
and this persistence could indicate that this proteinase
inhibitor is required for a longer time, both to neutralize
lysosomal hydrolases released by infiltrated macrophages
and neutrophils and, more importantly, to induce release
of anti-inflammatory cytokines. However, enhanced levels
of ceruloplasmin, α1-antitrypsin, and, in general, plasma α
fraction proteins have also been observed in several parasitic
diseases, even though there was no relationship between their
changes and disease evolution [58, 59].
2.4. Immunologic Transition from Innate to
Acquired Immunity
2.4.1. Toll-Like Receptors, Dendritic Cells, and the Innate
Immune System. One of the mechanisms by which the
innate immune system senses the invasion of pathogenic
microorganisms is through pattern-recognition receptors
(PRRs), which are germ-line-encoded receptors, including
transmembrane Toll-like receptors (TLRs), and cytoso-
lic nucleotide-binding oligomerisation-domain-(NOD-) like
receptor (NLR) family proteins [48, 49]. Recognition of
pathogen-associated molecular patterns by TLRs, either
alone or as heterodimers with other TLR or non-TLR recep-
tors, triggers signals which are responsible for activation of
genes important for an eﬀective host defense, especially those
of inflammatory cytokines [60, 61]. There are at least 10
TLRs in humans. TLR signalling is mediated via interactions
with adaptor proteins, including MyD88 and toll-receptor-
associated activator of interferon (TRIF) [62]. Toll-like
receptor 4 (TLR4) has an important role in inflammation
and immunity, and its expression has been reported in most
tissues of the body. TLR4 is well known as receptor for
LPS, and its activation is critical for response to gram-
negative bacteria. Recently, mutations in human TLR4 were
found to be associated with hyporesponsiveness to LPS and
increased risk of gram-negative infections both in humans
and experimental animals [63]. The +896 A→G non-
synonymous single-nucleotide polymorphism of the TLR4
gene, causing the Asp299→Gly change in the extracellular
domain of TLR4, attenuates receptor signalling, decreases
endotoxin responsiveness, and determines poor outcomes
from sepsis [64]. Interestingly, it has been demonstrated
that the +869G single-nucleotide polymorphism of the
TLR4 gene is overexpressed in BF patients with significant
diﬀerences in the frequency of TLR genotypes and alleles
between BF patients and age-matched controls. These data
might be interpreted as one hypothetical basis for genetic
susceptibility to BF [65].
The role played by dendritic cells (DCs), key initiators
and orchestrators of the immune response, is important to
understand in rickettsial infections. TLR4 signalling, due
to ligation with rickettsial LPS, is important in activating
antigen-presenting cells, for example, DCs, toward produc-
tion of proinflammatory cytokines (i.e., IL-2, IL-6, IL-12,
and IL-23), initiation of antirickettsial innate immunity
(namely, expansion of the natural killer (NK) cell population
and subsequent production of IFN-γ) and production of
adaptive TH1 type or TH17 responses (which play a critical
role in autoimmunity and are also implicated in protective
immune responses to bacterial pathogens). Conversely, lack
of TLR4 stimulation during antigen presentation leads to
disproportionate expansion of CD4+ CD25+ Foxp3- T-
regulatory lymphocytes (Treg) and subsequent suppression of
proinflammatory immune responses to rickettsiae. C3H/HeJ
mice, which are naturally defective in TLR4 signaling,
develop overwhelming, fatal rickettsial infections when
given an inoculum that is nonfatal for TLR4-competent
mice. C3H/HeJ mice have a reduced TH1-type response
and a significantly greater percentage of Treg cells in their
peripheral lymph nodes, which could potentially suppress
proinflammatory responses by production of IL-10 or trans-
forming growth factor-β (TGF-β), and limit the initiation
of adaptive immunity, by decreasing the number of eﬀector
cells during antigen stimulation (see below). In contrast,
mice with competent TLR4 responses are more resistant to
rickettsial infection. Moreover, this resistance is associated
with an increase in number of known antirickettsial eﬀector
cells, specifically TH1- and TH17-polarized CD4+ and CD8+
T lymphocytes [66, 67].
TLR4-ligated DCs induce recruitment of NK cells to
draining lymph nodes. Furthermore, this recruitment and
production of NK cell-derived IFN-γ in draining lymph
nodes are important in augmenting the TH1 immune
response. It has been documented that TLR4 stimulation is
also important in inducing NK cell activation in vivo. The
number and percentage of NK cells in spleen are consistently
lower in C3H/HeJ mice than in TLR4-competent ones after
R. conorii infection. Additionally, splenocytes from C3H/HeJ
mice have less NK cell cytotoxic activity in vitro than those
from TLR4-competent mice. Moreover, TLR4-competent
mice have significantly higher serum levels of IFN-γ during
early infection, and subsequent investigation demonstrated
that NK cells in TLR4-competent mice produce significantly
more IFN-γ after in vitro stimulation. This IFN-γ production
is important in inducing early NO production in infected
ECs [68].
Taken together, all these data reveal an important role
for DCs in recognizing rickettsiae through TLR4 and that
a vigorous proinflammatory response induced by DCs is
associated with protective immunity to rickettsiae. Subse-
quently, generation of antigen-specific immunity is crucial
to complete protection [66–68].
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Figure 4: Acute phase response in rickettsial diseases.
2.4.2. CD4+ Lymphocytes and Related Cytokines. In acute
BF patients, a reduction of circulating T cells, and, in par-
ticular, of CD4+ (helper/inducer T cells), CD4+/CD45RO+
(memory T cells), and CD4+/CD45+ (naive cells) subsets
have been demonstrated. These modifications could be
due to cell adhesion to vascular endothelium, followed by
their entrance into the sites of inflammation. Apoptosis,
spontaneous and/or activation-induced, could also have a
role in this diminution [69, 70]. Other lymphocytic subsets
(CD8+ (suppressor/cytotoxic T cells), CD16+ (NK cells),
and CD20+ [B cells)) tend to decrease but not statistically
significantly, whereas monocytes (CD14+/HLA-DR+) are
significantly increased. All cell subsets return to normal
levels after successful treatment except for monocytes, which
persist at a high level after recovery. Inflammatory and
immunologic responses, mediated by increased levels of
TH1-type (TNF-α and IFN-γ) and TH2-type cytokines (IL-
10 and IL-6), appear to be important for recovery from
infection. In detail, serum levels of TNF-α, IFN-γ, IL-10,
and IL-6 are significantly increased in patients with acute
BF, compared with those from control healthy subjects. On
the contrary, in vitro peripheral mononuclear cells from
acute BF patients produce low levels of IFN-γ and IL-
10 in response to mitogen or specific antigen, whereas
TNF-α and IL-6 responses are in the normal range. It is
possible that IFN-γ and IL-10 are produced at the sites of
infection, as observed in leishmaniasis, as a result of local
recruitment and accumulation of activated CD4+ T cells in
the perivascular area adjacent to infected ECs. Furthermore
this observation is compatible with observed reduction of
circulating CD4+ cells. In contrast, normal production of
TNF-α and IL-6 could be due to the presence of high levels of
peripheral monocytes, important sources of TNF-α and IL-
6 production. Dramatic increase in TNF-α in the first week
after onset of symptoms, together with IFN-γ, is one of the
early events observed in acutely ill BF patients, followed by
increases of IL-10 and IL-6. IFN-γ levels drop sharply in the
second week after onset of fever, whereas TNF-α, IL-10, and
IL-6 gradually decline, reaching normal levels after the third
week [69, 71].
Antigen-presenting cells activated by rickettsial antigens
produce high levels of TNF-α and IFN-γ. TNF-α induces
TNF-α and IFN-γ production from activated CD4+ T cells
with TH1 phenotype and NK cells. One important eﬀect of
TNF-α and IFN-γ on macrophages is induction of receptors
for TNF-α, so the binding of TNF-α on macrophages might
further activate these cells, by an autocrine TNF-α loop, thus
increasing their antirickettsial activity via induction of NO
synthesis (Figure 5) [72–74]. Persistence of high serum levels
of TNF-α in recovered patients could be a sign of residual
local lesions. Patients with severe forms of BF, associated with
disseminated intravascular coagulation, had very high levels
of TNF-α that persisted for a long time, and decreased only
when the condition of the patients improved. A relationship
has also been observed between serum TNF-α and a high
level of production of one of two soluble TNF receptors,
persisting high values of sTNF-RI in BF could be an indicator
of disease activity [69, 75].
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Because IL-10 (a TH2-type cytokine) suppresses the
ability of IFN-γ-activated macrophages to produce inflam-
matory mediators, its persistent high levels could be
owing to its ability to downregulate the potentially tissue-
damaging eﬀects of responses mediated by increased TH1-
type cytokines [76, 77].
The profile of serum IL-6 (another TH2-type cytokine)
production in patients with acute BF and after recovery
is similar to that of IL-10. In acute BF, high IL-6 levels
could be due to synthesis at sites of infection by activated
and damaged ECs, infiltrating monocytes, and TH2 T cells.
In acute BF, IL-6 could act as an inflammatory cytokine,
rather than as a growth and diﬀerentiation factor for B
cells and immunoglobulin production. The fact that B
cells are reduced in acute BF in the face of high levels
of IL-6 is consistent with this hypothesis [44, 69]. Later,
when IL-10 begins to inhibit TH1 cells that produce TNF-
α and IFN-γ, favouring proliferation and secretion of TH2
cytokines, such as IL-6, terminal diﬀerentiation of B cells to
immunoglobulin-producing cells could be favoured [69, 78].
In agreement with this scenario, there is normalization of
B cells in recovered patients. The specific antibody titer
increases only 2 weeks after infection and peaks in 4
weeks. Afterwards, IgM decreases, and IgG remains high
for several months [69, 79]. Since soluble IL-6R (sIL-6Rα)
could enhance rather than inhibit the biological activity of
IL-6 both in vitro and in vivo, the elevated levels of sIL-6Rα
detected in the first weeks of infection in BF patients might
result in increased IL-6 activity. In this case, IL-6-sIL-6Rα
complexes could act as strong activators of the inflammatory
response [69, 80].
Therefore, in BF patients, TH1- and TH2-type responses
are not characteristically polarised, as both activating (i.e.,
TNF-α, IFN-γ) and suppressive (i.e., IL-10 and IL-6)
cytokines are detected [81, 82]. It is possible that in BF, as
in any other inflammatory environment, counterbalancing
mechanisms are normally produced to curtail the process.
IL-10 and IL-6 are capable of derailing TH1-type responses
and deactivating macrophages, thereby moderating tissue
injury [83].
IL-12, a cytokine produced by B cells, phagocytic cells,
and other antigen-presenting cell types, induces cytokine
production, primarily IFN-γ, from T cells with TH1 phe-
notype and NK cells, acts as a growth factor for activated
T cells and NK cells, enhances the cytotoxic activity of
NK cells, and favours cytotoxic T-lymphocyte generation,
thus exerting stimulatory eﬀects on TH1-type responses
and downregulating TH2-type activity [84]. In BF patients,
IL-12, predominantly produced by monocytes, appears to
act very early, favouring TH1 diﬀerentiation and TH1-type
cytokine production and contributing to phagocytic cell
activation and innate resistance to intracellular pathogens.
Therefore, IL-12 could, if produced in eﬀective amounts,
favour rickettsial clearance, activating the TH1 responses, as
observed in other intracellular infections [84, 85].
Finally, some authors have described the occurrence
in patients with BF of haemophagocytic lymphohistiocy-
tosis (or haemophagocytic syndrome), a potentially fatal
hyperinflammatory syndrome, characterized by histiocyte
proliferation and haemophagocytosis. The pathophysiology
of haemophagocytic lymphohistiocytosis in BF patients is
not fully understood. However, an uncontrolled immune
response can lead to hypersecretion of cytokines, upregu-
lation of adhesion molecules and MHC I and II molecules
onmonocytes-macrophages, and expansion of inflammatory
monocytes, together with impaired or absent function of NK
cells and cytotoxic T cells. This exaggerated inflammatory
response could result in uncontrolled proliferation and
phagocytic activity of histiocytes [86].
2.4.3. Role of CD8+ T Cells. CD8+ T lymphocytes, perhaps
activated by antigen-presenting ECs, in association with
antigens on class I of major histocompatibility complex
(MHC-I), contribute to protective immunity to rickettsiae
by both MHC-I-restricted cytotoxic T-lymphocyte (CTL)
activity and production of IFN-γ. However, CTL activity
might be more critical to recovery from rickettsial infection
than the eﬀects of IFN-γ production by CD8+ T cells
(Figure 5). Therefore, CD4+ and CD8+ T lymphocytes
are both a potentially rich source of IFN-γ, which could
activate endothelial rickettsicidal activity and tip the balance
in favour of survival. However, in mice, depletion of CD4+
cells has no observed eﬀect on course or outcome of
infection. In contrast, CD8+-depleted mice, infected with
ordinarily sublethal dose of R. conorii, remain persistently
infected and ill, and a high proportion of these animals
die of uncontrolled rickettsial infection and its consequent
pathologic eﬀects. Rickettsia-infected ECs, and to a lesser
extent, rickettsia-infected macrophages, are the targets of
MHC-I-restricted CTL-mediated clearance of the infection.
Perforin is one of the mechanisms of elimination of R.
conorii-infected cells, but it is probably not the only one.
As of yet, the roles of Fas-Fas ligand interaction and/or
granulysin, in antirickettsial CTL activity, might also be
important [87, 88].
2.4.4. Other Markers of Immunologic Activation. The strong
T-cell activation, during BF, is also attested by observation of
a very significant release of the α-chain of high-aﬃnity IL-
2R, in soluble form (s-IL2R), in serum and urine of acute
BF patients [89]. IL-2R is the main cellular mediator of the
actions of IL-2, as a growth and diﬀerentiation factor for T,
B, and NK cells and as an activator for macrophages. sIL-
2R, released both in vitro and in vivo following lymphocyte
activation, binds IL-2, and, thus, it potentially downregulates
IL-2-driven proliferation and IL-2-dependent cell-mediated
responses [90]. sIL-2R is significantly increased in acute BF
and returns to normal when patients recover from disease.
Serum levels of sIL-2R correlate positively with those in
urine, indicating that sIL-2R undergoes glomerular filtration
[89].
Other markers produced by functionally active lympho-
cytes such as soluble CD4 (sCD4), soluble CD8 (sCD8), β2-
microglobulin (β2-M), and soluble class I antigens (sHLA-
I) are released, in the sera of patients with acute BF,
and correlate with the evolution of infection [91]. The
pathophysiological functions of these molecules are not
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Figure 5: Immunologic alterations in rickettsial diseases.
known. It is likely that sHLA-I, shed as dimers with β2-
M, contains the peptide of foreign rickettsial antigen within
the groove, and in such a way it can potentially recognize
reactive T cells. Thus, sHLA-I could play a relevant role in
regulating the immune response, being released by activation
and contributing itself to activation of other cells [92, 93].
2.4.5. Role of CD4+ CD25+ Foxp3- T Regulatory (Treg)
Lymphocytes. Acute severe human rickettsial diseases have
been characterized as diseases that stimulate a dominant
type 1 immunity and unresponsiveness or suppression
of CD4+ T cells, with transient immune dysregulation.
There is a suppressed CD4+ TH1-cell response during
lethal rickettsial infection in susceptible C3H/HeN mice
(that mimic the pathogenesis of severe human rickettsial
infection), including inhibition of IFN-γ production by
spleen cells in response to rickettsial stimulation compared
to production in sublethally infected mice, a serum level of
IFN-γ significantly lower than that in sublethally infected
mice, suppressed or unresponsive proliferation of CD4+ T
cells in response to anti-CD3 or specific antigen stimulation,
inhibition of IL-2 production by splenocytes, and, finally, a
lower frequency of antigen-specific IFN-γ-producing CD4+
T cells than that in sublethally infected mice. Immunosup-
pression induced by a high dose of rickettsiae may account
for the uncontrolled bacterial burden and overwhelming
infection. The suppressed immune response observed in
mice infected with a lethal dose of R. conorii is associated
with substantial, significantly greater expansion of Treg
cells in the infection sites. Therefore, generation of Treg
cells might be a potential mechanism contributing to host
susceptibility to acute severe rickettsiosis. In particular, it has
been demonstrated that DCs from resistant C57BL/6 mice
exhibit higher expression levels of MHC class II and higher
IL-12 production upon rickettsial infection and are more
potent in priming naı¨ve CD4+ T cells to produce IFN-γ,
whereas DCs from susceptible lethally infected C3H mice
promote the induction and expansion of a novel phenotype
of suppressive CD4+ CD25+ T-bet− Foxp3− CTLA-4high T-
reg cells, consisting of both IL-10-producing adaptive Treg
cells and IFN-γ-producing T-eﬀector cells. This novel TH1-
cell-related adaptive Treg-cell population contributes greatly
to deep immunosuppression during acute severe rickettsiosis
via as-yet-unidentified mechanisms that may involve IL-10
production, or CTLA-4 (cytotoxic T-lymphocyte antigen 4)
function, or an indirect process via an influence on DCs. It is
also possible that IL-10-producing antigen-presenting cells,
such as DCs, are involved in immunosuppressive phenomena
in addition to the suppression mediated by Treg cells and
that interactions between DCs and Treg cells, rather than Treg
cells alone, may play a crucial role in the balance between
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an eﬃcient immune response and tolerance/susceptibility
[94, 95].
2.4.6. Intralesion Production of Cytokines and Chemokines in
BF. Very few human studies directly examined either the
local mediators of inflammation or the immune response at
the site of infection (e.g., skin) in rickettsial diseases. Skin-
biopsy samples from patients with BF, collected 3–14 days
after onset of fever, revealed a balanced mixed type 1, pro-
inflammatory and anti-inflammatory responses, as reflected
by elevated levels of mRNA expression of TNF-α, IFN-γ,
and IL-10. Increased levels of IL-10 suggest the presence of
an immunoregulatory mechanism that can help to avoid
severe tissue damage due to excess intralesional production
of proinflammatory type 1 cytokines. There is also a positive
correlation between high levels of IFN-γ mRNA and TNF-α
mRNA and the production of enzymes involved in limiting
microbial growth (i.e., iNOS and IDO). Finally, although
the median mRNA-expression levels of IFN-γ, TNF-α, IL-10,
iNOS, and IDO were not statistically significantly diﬀerent
between patients with mild, moderate, and severe MSF, there
was a trend toward expression of substantially higher levels
of certain biomolecules in either mild or severe MSF. In
detail, patients with severe BF showed higher levels of TNF-
α mRNA and lower levels of IFN-γ mRNA compared with
those of mild BF. All of the patients with severe BF had higher
IDO and RANTES mRNA-expression levels and lower levels
of iNOS mRNA compared with those of mild BF. The level
of IL-10 mRNA expression was comparable in all 3 groups of
patients. Therefore, IFN-γ is critical for protection against
severe BF, and protection is dependent on the expression
of iNOS mRNA, whereas TNF-α and RANTES may play a
dual role, being involved in both protective antirickettsial
immunity and the pathogenesis of severe BF [96].
3. Orientia tsutsugamushi
Orientia tsutsugamushi infects predominantly ECs, even
though it may be found in several other cells, including DCs,
macrophages, polymorphonuclear leukocytes (PMNs), and
lymphocytes. The bacterium invades host cells by induced
phagocytosis and then is taken into a phagosome. Loss of
phagosomal membranes is frequently observed, suggesting
a mechanism for O. tsutsugamushi escape from phagosome
into cytoplasm. The virulence factors related to phagosomal
membrane lysis, however, have not been identified. Then
O. tsutsugamushi usually propagates in host cytoplasm via
binary fission. Groups of budding Orientia (the budding
process diﬀers from that of enveloped viruses as the host
cell membrane surrounds the bacterial cell wall rather than
being incorporated into the organisms’ structure) are clearly
observed on the cell surface after 2-3 days of incubation.
The released bacterium covered by host cell membrane
may either directly infect neighboring cells by fusion of
membranes or the surrounding host cell membrane may be
lost, leaving naked Orientia to invade other cells [97].
3.1. Invasion, Injury, and Activation of Infected Target Cells
3.1.1. ECs, Dendritic Cells, and Macrophages Invasion. Bac-
terial invasion of host cells is primarily mediated by
interactions between bacterial surface components and
complementary host receptors, which stimulate host signal
transduction pathways required for bacterial access. O. tsut-
sugamushi uses host fibronectin interactions with one of its
outer membrane proteins, the 56-kDa type-specific antigen
(TSA56), to carry out internalization. Then, fibronectin
facilitates bacterial entry into the host cells via interactions
with integrins, that is, α5β1. After integrin engagement,
signaling molecules at the inner surface of the plasma
membrane, which act as integrators of responses to extracel-
lular stimuli, are activated. In detail, focal adhesion kinase
(FAK), Src kinase, and RhoA GTPase are activated by O.
tsutsugamushi invasion, and the signaling adaptors talin and
paxillin are recruited to the site of infection. Furthermore,
extensive actin reorganization and membrane ruﬄing in the
region surrounding the O. tsutsugamushi cells are induced
within 10min. after attachment. Therefore,O. tsutsugamushi
exploits integrin-mediated signaling and rearrangements
of the actin cytoskeleton for invasion of eukaryotic host
cells. However, many other membrane proteins, as well
as TSA56 (e.g., products of sca genes), may interact with
other receptors to trigger the observed downstream signaling
events, involving recruitment of host endocytic machinery
components and their specific activation, which ultimately
lead to the extensive actin reorganization required for
pathogen entry [98, 99] (Figure 6).
3.1.2. ECs, Dendritic Cells, and Macrophages Activation.
Inflammation is initiated by O. tsutsugamushi-infected cells
in the dermis. Proinflammatory cytokines and chemokines
secreted by activated DCs, that is, TNF-α, IL-13β, IL-
6, macrophage inflammatory protein (MIP)-1 α/β, MIP-
2, and MCP-1, are the main ones responsible for leuko-
cyte recruitment into inflammatory tissues. Members of
the CC chemokine subfamily, which include MIP-1 α/β
(CCL3/CCL4), MCP-1 (CCL2), and RANTES (CCL5), pref-
erentially attract monocytes and lymphocytes, while those
of the CXC chemokine subfamily, such as IL-8 and MIP-
2 (CCL8), are potent neutrophil attractants. While CC
chemokines, such as MIP-α/β and RANTES, are eﬃcient
chemoattractants for TH1 cells, TH2 cells were not attracted
by them. Stimulation of T cells in the presence of MIP-
1α enhances production of IFN-γ by TH1 cells, while
stimulation of T cells in the presence of MCP-1 leads to
an increase of IL-4 production (a TH2 cytokine). Taken
together, T-cell diﬀerentiation by a subset of chemokines
produced by activated DCs might be a crucial factor in
the induction of a resistant versus a susceptible immune
response to Orientia infection (Figure 7). ECs are another
key participant in the inflammation process. Activation of
ECs is stimulated by proinflammatory cytokines, including
TNF-α and IL-1, which are released from infected sites
and result in the upregulation of cell adhesion molecules,
such as P-selectin, E-selectin, ICAM-1, and VCAM-1, to
promote cellular influx via transendothelial migration, as
14 Clinical and Developmental Immunology
Orientia infection
Interaction of Orientia TSA56
with host macrophage fibronectin
Fibronectin-Integrin α5β1 association
Macrophages and
endothelial cellsSignal transduction,
via FAK, Src kinase, RhoA GTPase,
and signaling adaptors recruitment
(talin and paxillin)
Extensive actin reorganization
Membrane ruﬄing Orientia phagocytosis
Phagosome
Figure 6: Orientia macrophages and endothelial cells invasion.
well as production of cytokines and chemokines, such as
IL-1α, IL-6, IL-8 (CXCL8), IL-10, IL-15, TNF-α and TNF-
β, CXCL1 to 3 (Gro), MCP-1 (CCL2), CCL5, and CCL17,
to initiate and propagate local inflammatory responses
(Figure 8). In addition, in patients with scrub typhus, the
serum levels of soluble L- and E-selectin correlate with
the symptoms of disease. MIP-1 α/β (CCL3/CCL4), MCP-
1 (CCL2), and RANTES (CCL5), produced by activated
macrophages, are induced via NF-κB activation, whereas
activated ECs generate MCP-1 (CCL2) and CXCL8 (IL-8)
independent of NF-κB activation [100, 101].
3.2. Immunologic Transition from Innate to
Adaptive Immunity
3.2.1. Innate Immune System. As TLRs are important for
innate immunity to rickettsiae, NLR family proteins are
involved in innate immune mechanisms to Orientia infec-
tion. The NLR family is composed of 22 intracellular
molecular-pattern-recognition molecules. One subfamily
includes NOD1 and NOD2, which sense peptidoglycan
polymers from cell wall components. Activation of NOD1
and NOD2 triggers recruitment of the adapter protein
receptor-interacting serine-threonine kinase 2 (RIPK2 or
RIP2), followed by activation of NF-κB andMAPKs. Another
subfamily includes the NLRP proteins, which are essential
for regulation of caspase-1 activation via the N-terminal
pyrin domain by inflammasome formation, consisting of
NALP3, caspase recruitment domain (ASC), and caspase-
1. The NALP3 inflammasome then cleaves pro-IL-1β, pro-
IL-18, and pro-IL-33 to mature IL-1β, IL-18, and IL-
33, respectively. During O. tsutsugamushi infection, NOD1
senses an Orientia component in ECs and activates the
downstream pathway of NF-κB, which leads to production
of IL-32, an IL-18-induced cytokine, previously recognized
as natural killer cell transcript 4 (NK4). Such increased IL-
32 levels aﬀect secretion of proinflammatory cytokines, that
is, IL-1β, IL-6, and IL-8, as well as ICAM-1 expression in
ECs. In addition, in ECs, IL-1β induces IL-32 production,
followed by an increase in the levels of IL-1β, IL-6, IL-8,
and ICAM-1. Therefore, IL-32-induced IL-1β expression in
O. tsutsugamushi-infected ECs may reciprocally enhance IL-
32 secretion. Consequently, IL-32 and IL-1β might form
a positive feedback loop on ECs during the process of
inflammation [102] (Figure 9).
3.2.2. CD4+ Lymphocytes and Related Cytokines. Type-1
cell-mediated immunity and IFN-γ production of T cells
in response to O. tsutsugamushi antigen is essential for
immune protection against infection, whereas the opposite
TH2 subset is considered to be detrimental. In animal
models (intraperitoneal injection of Orientia in mouse, not
perfectly corresponding to the natural modality of human
infection, via intradermal penetration), TH1- and TH2-
type responses are not clearly polarised, as both activating
(i.e., IL-12, IFN-γ) and suppressive (i.e., IL-10) cytokines
are simultaneously detected. It is possible in scrub typhus,
like in other infectious disease (e.g., visceral leishmaniasis),
that counterbalancing mechanisms are normally produced
to modulate the process and ensure homeostasis within
the host. Therefore, O. tsutsugamushi activates both proin-
flammatory and modulatory pathways, via IL-10, in the
early stages of infection. An early step in generating TH1
responses is IL-12 production by antigen-presenting cells
(DCs, phagocytes, and mesothelium), which targets natural
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killer cells and T cells, inducing IFN-γ production, whereas
early IL-10 production inhibits this response. IL-10 inhibits
production of TH1 type cytokines, including IFN-γ, IL-1,
IL-2, IL-3, GM-CSF, and TNF-α and thereby inhibits the
development of TH1 immunity that is essential for clearing
O. tsutsugamushi in infected ECs. In contrast, IFN-γ inhibits
proliferation of TH2 cells, thereby inhibiting production of
TH2-derived cytokines, including IL-4, IL-5, and IL-6 which
are essential for B-cell diﬀerentiation and isotype switching
[103].
Although the cytokine and chemokine profile demon-
strates that O. tsutsugamushi infection results in immune
reaction via soluble mediators from infected tissues or
cells, this intracellular bacterium seems to exploit immune
evasion mechanisms for survival. In addition, patients with
tsutsugamushi disease sometimes suﬀer from severe clinical
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complications in the absence of appropriate antimicrobial
chemotherapy. The exact mechanism leading to such severe
complications is not well understood yet. In animal models
(with the above-mentioned limitations), one of the pos-
sible mechanisms employed by O. tsutsugamushi involves
the suppression of proinflammatory cytokine production,
including TNF-α and IL-6, via induction of IL-10 secretion
from infected macrophages and mesothelium. It has been
reported that an imbalance of these two cytokines, with
low levels of TNF-α and high levels of IL-10, may be
important in worsening the condition of patients aﬀected
with bacterial infections. Alternatively, as an excessive
inflammation-related cytokine response during the initial
and essential host response to an infectious challenge
develops, it may lead to harmful, or even fatal, consequences,
as seen in septic shock or multiple organ failure, that is, SIRS.
In a life-threatening infection, systemic release of several
proinflammatory cytokines is not properly regulated, and
higher serum concentrations of inflammatory cytokines have
been strongly implicated in the development of SIRS. Some
studies demonstrated that serum levels of TNF-α have some
relationship with the severity of tsutsugamushi disease. The
TNF-α levels in the acute phase could predict the severity
of this infectious disease. As TNF-α is essential for host
defense, TNF-α underproduction may help proliferation of
the pathogen, whereas its overproduction may be harmful to
the host [104] (Figure 10).
3.2.3. Humoral Immunity. It is unclear if anti-Orientia
antibodies, appearing early enough in infection, really aﬀect
the course of infection, or if passive immunization only
reflects what might be a benefit of vaccination. However,
humoral immunity might play a role in protective immunity
to O. tsutsugamushi by inhibiting the events required in
attachment, entry, and/or traﬃcking and replication in the
cytoplasm. It has been demonstrated that antibodies enhance
opsonophagocytosis of O. tsutsugamushi by professional
phagocytes, such as macrophages and PMN. In addition,
antibodies inhibit invasion of O. tsutsugamushi into non-
professional phagocytes, such as ECs, epithelial cells, and
fibroblasts [105]. However, neither cytokines nor antibodies
alone enable macrophage cultures to completely suppress
oriential infection. This indicates that both cellular and
humoral immunity play a role in clearing O. tsutsuga-
mushi by facilitating uptake and ensuing intracytoplasmic
destruction of the bacterium. Although identification of
protective antigens is important to understand homotypic
and heterotypic immunity to scrub typhus, the molecules
that play important roles in generating protective immunity
are partially known. Antigenic heterogeneity among O.
tsutsugamushi strains is so pronounced that whole cell
vaccines prepared against one strain generally fail to protect
mice against infection from others. Orientia lacks both
peptidoglycan and LPS, containing the major strain-variable
56-kDa protein, as well as the antigenically variable 110-,
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47- and 25-kDa proteins. Among all antigens, the 56-kDa
protein is often recognized by both human and animal
host immune systems during infection. It is structurally
and functionally nearly identical to the eukaryotes’ protein
known as Heat Shock Protein (Hsp) 60. There is substantial
evidence indicating that heat shock proteins mainly serve
as target molecules in the anti-infectious or autoaggressive
immune responses. For these reason, the 58-kDa protein
should be carefully considered as a recombinant vaccine
candidate [106].
4. Ehrlichiosis
4.1. Target Cells. E. chaﬀeensis is confined to cytoplasmic
membrane-bound vacuoles within monocytes/macrophages
and DCs, replicating to form microcolonies, called morulae,
that contain one to over 400 organisms. Morphologically,
individual ehrlichiae are coccoid and coccobacillary and
exhibit two ultrastructural cell types: a larger reticulate
and a smaller dense-cored cell. Ehrlichia reticulate cells
and dense-cored cells represent the bacterial replicating and
infectious forms, respectively. The dense-cored cell form of
E. chaﬀeensis binds to the host cell surface where it is rapidly
internalised and completes the developmental cycle within
72 h [107].
4.2. Invasion, Injury, and Activation of Target Cells
4.2.1. Monocyte/Macrophage and Dendritic Cell Invasion.
The presence of long-period tandem repeats distributed in
intergenic regions of Ehrlichia is well recognised. They have
also been found in a small group of ehrlichial proteins,
named “tandem repeat proteins” (TRPs), that is, TRP120
and TRP47, associated with host-pathogen interactions, such
as adhesion, internalisation, actin nucleation, and immune
evasion [108].
Infection of the host cell involves dense-cored ehrlichiae
that express TRP120 on the surface. It has important role
in the binding and entry process, and a potential role has
also been demonstrated for TRP47. Ehrlichiae binding to
the host cell occurs through membrane receptors, such as
E- and L-selectin and other glycosylphosphatidylinositol-
anchored proteins located in caveolae (tiny indentations in
the cell surface membrane), triggering receptor-mediated
endocytosis that involves signalling transduction events,
including transglutamination, tyrosine phosphorylation,
phospholipase Cγ2 activation, inositol-(1,4,5)-trisphosphate
(IP3)- production and increases in the intracellular calcium
concentration. The vacuoles in which the organism enters
contain caveolin-1, GM1 ganglioside, and phospholipase
Cγ2. Later, after infection, vacuoles containing replicating
ehrlichiae show the characteristics of early endosomes (i.e.,
the presence of Rab5A, early endosomal antigen 1 (EEA1),
and vacuolar (H+) ATPase, together with vesicle-associated
membrane protein 2, major histocompatibility class II
and β2-microglobulin) and accumulate transferrin and its
receptor. As a matter of fact, Ehrlichia survival depends on an
available supply of intracellular iron, and the antiehrlichial
activity of IFN-γ is mediated by limiting cytoplasmic iron
availability (see below) [109–111] (Figure 11).
4.2.2. Modulation of Host Cell Gene Expression. Ehrlichia
chaﬀeensis seems to actively modulate host cell gene tran-
scription and function despite the fact that the bacterium
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Figure 11: Ehrlichial monocytes/macrophages and dendritic cells invasion.
develops exclusively inside a vacuolar inclusion, separated
from host cell cytosol by a host membrane. Therefore, host
cell gene transcription modulation is related to secretion of
specific ehrlichial eﬀector proteins into the host cell cytosol,
which requires active secretion systems. Such delivery
mechanisms have been identified and include many of the
known type IV secretion system (T4SS) components; Sec-
dependent and Sec-independent protein export pathways for
protein secretion across the membrane, as well as a putative
type I secretion system (T1SS), have also been identified.
A consequence of eﬀector proteins-host-cell interaction is
downregulation of transcription factors and transcription
of target genes related to host defence and other cellular
functions, at least in part by inhibition of host mitogen-
activated protein (MAP) kinases. Discovery of Ehrlichia
DNA-binding proteins (i.e., TRP120 and Ank200) provides
another mechanism by which host cell gene transcription
can be directly modulated. Specific cellular processes which
appear to be modulated are membrane-traﬃcking proteins,
expression of proinflammatory cytokines, and infected cell
apoptosis [112, 113].
Ehrlichia chaﬀeensis lives in early endosome and inhibits
its maturation to evade fusion with lysosomes and destruc-
tion by lysosomal enzymes. Moreover, E. chaﬀeensis inhibits
transcription of genes involved in membrane traﬃcking
and lysosomal fusion, such as Rab5, synaptosome-associated
protein 23 (SNAP23), and syntaxin 16 (STX16) [114]
(Figure 11).
Survival in mononuclear phagocytes requires the ability
to evade the innate and adaptive immune responses (see
also below). Ehrlichia chaﬀeensis inhibits transcription of
cytokines involved in the early innate immune response and
cell-mediated immune response to intracellular bacteria. As
a matter of fact, this bacterium avoids stimulation of IL-12
production and represses IL-15 and IL-18 production; these
cytokines play fundamental roles in stimulating TH1 and NK
cells to produce IFN-γ, which then promotes macrophages’
killing of phagocytosed bacteria. IL-12 and IL-15 also activate
destruction of cells infected with intracellular bacteria by NK
cells and cytotoxic T lymphocytes. Thus, repression of IL-12,
IL-15, and IL-18 may help E. chaﬀeensis to evade the host’s
innate and adaptive immunity [109].
Apoptosis is an innate cellular defence mechanism
against microbes that is modulated by many bacterial
pathogens, and there are new data that indicate that
Ehrlichia alsomodulate host cell death. Formost intracellular
pathogens, apoptosis induction leads to pathogen killing and
infection clearance, and this is thought to be beneficial to the
host and to enhance the immune response to the infection.
Delaying or preventing apoptosis could be a mechanism to
enhance ehrlichial survival by preventing host cell death and
subsequent immune recognition. In the case of ehrlichial
infection, there seem to be several mechanisms involved in
apoptosis modulation and inhibition. Modulation of genes
associated with inhibition of apoptosis, cell cycle regulators,
and mitochondrial function is observed early during E.
chaﬀeensis infection and is probably necessary for delaying
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host cell death. Particularly, E. chaﬀeensis infection both
upregulates transcription of apoptosis inhibitors, such as
NF-κB, IER3, BIRC3, and BCL2A1, and inhibits apoptosis
inducers, such as BIK and BNIP3L, which initiate apoptosis
by inactivating BCL2 proteins, thus impairing host cell
apoptosis and maintaining a prolonged growth opportunity
for ehrlichiae. At the same time, during the early infec-
tion stages, E. chaﬀeensis modulates genes related to the
cell cycle, including cyclin G1 and CDC2-related protein
kinases (CDKs). However, in the late stages of infection, E.
chaﬀeensis upregulates cyclin E and CDC25, which activate
cell replication. Thus, E. chaﬀeensis both arrests the host cell
in the G1 stage during the early stages of infection to establish
itself inside the cell and, in the late stages, upregulates
cell proliferation to prevent the cell from dying because
of progressive infection [115]. Finally, in Ehrlichia-infected
cells, mitochondria are redistributed around Ehrlichia moru-
lae, and mitochondrial metabolism is inhibited. A dormant
mitochondrion may not trigger apoptosis in the infected
cell. Thus, Ehrlichia recruits mitochondria to manipulate
mitochondrial metabolism, which may result in host cell’s
apoptosis inhibition. Close apposition of mitochondria and
Ehrlichia may be required for bacteria to eﬀectively deliver
proteins to mitochondria and inhibit the mitochondrial
apoptosis pathway. In detail, E. chaﬀeensis downregulates
JNK2 during the early stage of infection and upregulates
DUSP8 and DUSP14, which dephosphorylate and inactivate
JNK2. JNKs are basal in apoptosis regulation. As a matter of
fact, absence of JNKs causes a defect in the mitochondrial
death signalling pathway and cell apoptosis by inhibiting
cytochrome c release [116] (Figure 12).
4.2.3. Exit Mechanisms. The mechanism by which Ehrlichia
is released from host cells or transported between cells is
not fully established. Recently, it was demonstrated that
Ehrlichia is transported to neighboring cells through the host
cell filopodium during the initial stages of infection but is
released by local host cell membrane rupture adjacent to
the morula during later stages of infection. Filopodia are
thin cell surface protrusions containing bundles of parallel
actin filaments. They are designed to explore the extracellular
matrix and surfaces of other cells, identifying adhesion
targets or navigating to its appropriate target. So cellular exit
of pathogenic microorganisms could be supported by host
cells’ filopodia, and it has been observed that Ehrlichia uses
this exit mechanism. An advantage of Ehrlichia transport
through the filopodia is that the pathogen evades the host’s
immune system travelling cell to cell [117].
4.2.4. Ehrlichial Eﬀectors and Molecular Host Interactions.
Significant progress has been made in the identification of
the host cell processes which Ehrlichia modulates. However,
the eﬀector proteins involved in manipulating these host cell
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processes have been largely undetermined. Recent studies
have focused attention on two small groups of Ehrlichia-
encoded proteins: those containing tandem and ankyrin
repeats. These proteins appear to be eﬀectors involved in
novel, complex, and multidimensional molecular strategies
to reprogram host cell defence mechanisms. Particularly,
two proteins, TRP47 and Ank200, have been emphasized
in recent studies, demonstrating interactions with host cell’s
DNA and proteins associated with distinct host cell processes
[118].
A recent study evaluatingmolecular interactions between
TRP47 and host cells pointed out several interactions of this
protein with several specific host cell targets. The strongest
observed interaction between Ehrlichia and host proteins is
between TRP47 and polycomb group ring finger 5 (PCGF5),
which has important roles in regulation of HOX gene expres-
sion (involved in early embryonic development), X chromo-
some inactivation, maintenance of stem cell pluripotency,
tumourigenesis, and stimulation of E3 ubiquitin ligase
activity (involved in targeting proteins to be degraded within
cells). Another interesting interaction is between TRP47 and
immunoglobulin lambda-like polypeptide 1 (IGLL1), the
surrogate light chain associated with the pre-B-cell receptor
involved in signal transduction for cellular proliferation,
diﬀerentiation from the pro-B-cell to pre-B-cell stage, allelic
exclusion at Ig heavy-chain gene locus, and promotion of Ig
light-chain gene rearrangements. Association of TRP47 with
FYN tyrosine kinase, known to specifically phosphorylate
caveolin-1 required for coxsackievirus internalisation and
infection by caveolin-associated vesicles of epithelial cells,
suggests that these proteins and their interaction might
be involved in host cell attachment or entry. TRP47 also
interacts with protein tyrosine phosphatase nonreceptor
type 2 (PTPN2), also known as T-cell protein tyrosine
phosphatase, which catalyses dephosphorylation of phos-
photyrosine peptides and regulates phosphotyrosine levels
in signal transduction pathways. Thus, it is involved in
haematopoietic cell development and also in several human
illnesses from autoimmune disease to cancer. PTPN2 has sev-
eral substrates, including many JAK-STAT pathway proteins.
Therefore, TRP47 might be involved not only in cellular
developmental regulation but also in inhibition of IFN-γ-
induced tyrosine phosphorylation of JAK and STAT proteins
by interacting with PTPN2. Finally, TRP47 interacts with
the multifunctional adenylate cyclase-associated protein 1
(CAP1), which has an active role in endocytosis, vesicle traf-
ficking, actin turnover, and in apoptosis enhancement. Thus,
in an eﬀort to survive in the intracellular niche, Ehrlichia
might manipulate cytoskeletal components of mononuclear
phagocytes, such as actin, facilitating endocytosis and vesicle
traﬃcking, and inhibiting apoptosis by modulating CAP1
activity [119] (Figure 13).
Ank200, one the four ehrlichial proteins with the ankyrin
(Ank) repeat motif present in eukaryotic cells and in
Ehrlichia species, has recently been detected in host cell
nuclei of E. chaﬀeensis-infected cells, where it interacts
with an adenine-rich motif in promoter and intronic
Alu elements. Alu elements are short, interspersed mobile
DNA elements distributed in a nonrandom scheme, which
comprise approximately 5–10% of the human genome,
and appear to be involved in transcriptional regulation.
Global analysis of Ank200 binding sites demonstrates that
this protein binds to several regions distributed on nearly
every chromosome by direct DNA interaction or via other
DNA-binding proteins. The host cell processes targeted
by Ank200 include genes associated with transcriptional
regulation, structural associations with the nucleus, and
apoptosis. Several Ank200 target genes have been linked
to pathogenesis and immune evasion, including JAK-STAT
pathway proteins (see also above) and TNF-α. One of
primary mechanisms by which E. chaﬀeensis survives in the
host cell appears to be by blocking macrophage respon-
siveness to IFN-γ. Furthermore, JAK2 transcription appears
to be silenced during E. chaﬀeensis infection, at least in
part, by the the ehrlichial Ank200-host DNA interaction.
TNF-α expression is not induced early in infection, but its
expression is upregulated approximately 30-fold by the day
5 after infection. E. chaﬀeensis Ank200 might contribute to
TNF-α induction by directly binding to the promoter and
upregulating gene transcription. Overproduction and high
serum concentration of TNF-α are closely associated with
fatality in severe monocytotropic ehrlichiosis [115, 120].
4.3. Immunologic Transition from Innate to
Adaptive Immunity
4.3.1. Ehrlichial Evasion of Innate Host Defences. Ehrlichia
manipulates innate immune defence mechanisms, including
apoptosis (see above), lysosomal fusion, production of
reactive oxygen species (ROS), IFN-γ responsiveness by
macrophages, and, in general, modulation of cell signalling
pathways.
Phagolysosomes represent an important innate host
defence mechanism against pathogens. Ehrlichia are able to
inhibit fusion of phagosomes containing themselves with
lysosomes and thus prevent their destruction by lysosomal
enzymes. In this context, three two-component systems,
named PleC-PleD, NtrY-NtrX, and CckA-CtrA, respectively,
have an important role in preventing lysosomal fusion. These
two-component systems, which control the response and
adaptation to a variety of environmental conditions, consist
of a sensor, associated with histidine kinase that detects envi-
ronmental signals, and a cognate response regulator that has
DNA-binding activity and regulates gene transcription. Cells
treated with closantel, an inhibitor of the histidine kinase
component, and incubated with E. chaﬀeensis have increased
colocalisation between E. chaﬀeensis and lysosomes [121].
Ehrlichia chaﬀeensis is highly sensitive to O2
− killing and
lacks genes involved in detoxification of ROS. However, it
actively blocks O2
− generation and causes degradation of
the NADPH oxidase subunit p22phox involved in ROS pro-
duction. Degradation of p22phox is due to nonproteasomal
proteolysis mediated by heat-labile factors or proteins from
E. Chaﬀeensis [122].
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The macrophage-activating cytokine IFN-γ has an
important role in innate and adaptive immune responses
against intracellular pathogens. Activation of macrophages
by IFN-γ induces several antimicrobial eﬀector mechanisms,
including regulation of iron homeostasis and ROS produc-
tion. As aforesaid, the ability to acquire iron is important
for survival of intracellular pathogens, such as Ehrlichia.
The antiehrlichial activity of IFN-γ is mediated by limiting
availability of cytoplasmic iron via reduction of surface
transferrin receptor. However, E. chaﬀeensis upregulates
transferrin receptor expression to counteract downregula-
tion induced by the action of IFN-γ. The ability of E.
chaﬀeensis to block the antimicrobial mechanisms of IFN-γ is
mediated, at least in part, by inhibition of the JAK-STAT IFN-
γ signal transduction pathway, that is, inhibition of tyrosine
phosphorylation of JAK1 and STAT1, normally induced
by IFN-γ and mediated by the ehrlichial protein TRP47,
and/or transcriptional regulation of JAK-STAT expression by
the DNA-binding protein and nuclear eﬀector Ank200 (see
below) [111, 115, 123].
Ehrlichia chaﬀeensis also appears to modulate the host
innate immune response by influencing other cell signalling
pathways. Antimicrobial activities of macrophages become
progressively less responsive during E. chaﬀeensis infection
in association with downregulation of pattern recognition
receptors (PRR), including TLR2, TLR4, and CD14, which
act as a PRR, and the activity of the PRR transcription
factor PU.1, the activation of which has been linked to the
p38 MAPK-dependent pathway. Finally, Ehrlichia seems to
target host tyrosine kinases and phosphatases, that is, FYN
and PTPN2, but the downstream processes aﬀected by these
interactions are not known. In addition, E. chaﬀeensis infec-
tion downregulates protein kinases involving cell mobility
and cytoskeletal changes, such as ITK, TXK, and PAKs (i.e.,
PAK1, PAK2, and PAK7) (Figure 14) [113].
4.3.2. Ehrlichial Immunopathological Mechanisms and Dis-
ease. During E. chaﬀeensis infection, there is a rela-
tively low bacterial burden in blood and tissues in non-
immunocompromised patients. However, the clinical man-
ifestations, which may include fever, multiorgan failure,
and adult respiratory distress syndrome, suggest that the
pathogenesis of ehrlichiosis might involve immunopatho-
logical responses that are described as a toxic shock-like
syndrome. Experimental lethal infection is accompanied by
extremely high levels of serum TNF-α, high frequency of
splenic TNF-α-producing CD8+ T cells, decreased Ehrlichia-
specific CD4+ T-cell proliferation, low IL-12 levels in spleen,
and decrease in the quantity of ehrlichial antigen-specific
IFN-γ-producing CD4+ TH1 cells. Recent studies have also
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Figure 14: Ehrlichia evading innate host defences.
demonstrated that CD1d-restricted NKT cells, subsets of NK
T cells that are key players in host defense against various
microbial infections, might to be instrumental in induction
of the immunopathological responses [124, 125].
5. Conclusion
Over the centuries, rickettsial, oriential, and ehrlichial dis-
eases aﬀected humankind all over the world, and they are still
extremely widespread, remaining major health issues, with
significant morbidity and mortality. They can be considered
both reemerging and previously unrecognized diseases,
likely owing to lack of in-depth epidemiologic surveys and
application of appropriate tools for accurate diagnosis.
Advances in our understanding of Rickettsia-, Ori-
entia-, and Ehrlichia-host interactions, target cells, viru-
lence mechanisms, structures of bacterial eﬀector proteins,
upstream signalling pathways and signal transduction sys-
tems, modulation of gene expression, host immunologic
responses, apoptotic elimination of infected cells, and,
finally, immunopathological basis of clinical manifestations
provided new targets for therapies to block host-pathogen
interactions and pathogen virulence mechanisms.
Additional therapeutic approaches have been also
identified, involving immunomodulatory therapies (i.e.,
antibodies-inhibiting interactions between eﬀector proteins
and host targets, inhibition of cytokine production, neu-
tralization of cytokine eﬀects, blocking specific cytokine
receptors) and vaccine development, resulting in pathogen
clearance by the immune system.
In rickettsial diseases, agents able both to quench harmful
ROS production and to potentiate cellular protective mech-
anisms against oxygen radicals represent promising rationale
for new and improved supplemental treatment. In this
context, new therapeutic approaches in treating rickettsial
infections and related vascular injuries are represented by
the use of naturally occurring biologic antioxidants to
preserve homeostasis at sites of vascular damage and by
pharmacologic or genetic approaches targeting HO-1 or
COX-2 in the vessel wall.
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